These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

856 related items for PubMed ID: 16489022

  • 21. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA, Dong Z, Ng S, Banville M, Zwaagstra JC, O'Connor-McCourt MD, Siegel PM.
    Oncogene; 2009 Feb 19; 28(7):1005-15. PubMed ID: 19079339
    [Abstract] [Full Text] [Related]

  • 22. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R.
    J Bone Miner Res; 2001 Aug 19; 16(8):1486-95. PubMed ID: 11499871
    [Abstract] [Full Text] [Related]

  • 23. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
    Wang P, Chen Z, Meng ZQ, Fan J, Luo JM, Liang W, Lin JH, Zhou ZH, Chen H, Wang K, Shen YH, Xu ZD, Liu LM.
    Carcinogenesis; 2009 Sep 19; 30(9):1497-506. PubMed ID: 19546161
    [Abstract] [Full Text] [Related]

  • 24. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F, Byfield SD, Parks WT, Stuelten CH, Nemani D, Zhang YE, Roberts AB.
    Cancer Res; 2004 Jul 01; 64(13):4523-30. PubMed ID: 15231662
    [Abstract] [Full Text] [Related]

  • 25. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
    Labelle M, Schnittler HJ, Aust DE, Friedrich K, Baretton G, Vestweber D, Breier G.
    Cancer Res; 2008 Mar 01; 68(5):1388-97. PubMed ID: 18316602
    [Abstract] [Full Text] [Related]

  • 26. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S, Rittling SR, Partridge NC, Benson CS, Thiyagaraj M, Srinivasan N, Selvamurugan N.
    J Cell Biochem; 2009 Oct 01; 108(2):408-14. PubMed ID: 19582787
    [Abstract] [Full Text] [Related]

  • 27. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT.
    J Clin Invest; 1993 Dec 01; 92(6):2569-76. PubMed ID: 7504687
    [Abstract] [Full Text] [Related]

  • 28. The RING finger protein11 binds to Smad4 and enhances Smad4-dependant TGF-beta signalling.
    Azmi PB, Seth AK.
    Anticancer Res; 2009 Jun 01; 29(6):2253-63. PubMed ID: 19528490
    [Abstract] [Full Text] [Related]

  • 29. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
    Bandyopadhyay A, Zhu Y, Cibull ML, Bao L, Chen C, Sun L.
    Cancer Res; 1999 Oct 01; 59(19):5041-6. PubMed ID: 10519421
    [Abstract] [Full Text] [Related]

  • 30. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 31. cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
    Son J, Lee JH, Kim HN, Ha H, Lee ZH.
    Biochem Biophys Res Commun; 2010 Jul 23; 398(2):309-14. PubMed ID: 20599715
    [Abstract] [Full Text] [Related]

  • 32. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, Jechlinger M, Waerner T, Weith A, Beug H, Mikulits W.
    Oncogene; 2006 May 25; 25(22):3170-85. PubMed ID: 16607286
    [Abstract] [Full Text] [Related]

  • 33. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells.
    Müller N, Reinacher-Schick A, Baldus S, van Hengel J, Berx G, Baar A, van Roy F, Schmiegel W, Schwarte-Waldhoff I.
    Oncogene; 2002 Sep 05; 21(39):6049-58. PubMed ID: 12203117
    [Abstract] [Full Text] [Related]

  • 34. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells.
    Safina A, Vandette E, Bakin AV.
    Oncogene; 2007 Apr 12; 26(17):2407-22. PubMed ID: 17072348
    [Abstract] [Full Text] [Related]

  • 35. Tranilast inhibits the growth and metastasis of mammary carcinoma.
    Chakrabarti R, Subramaniam V, Abdalla S, Jothy S, Prud'homme GJ.
    Anticancer Drugs; 2009 Jun 12; 20(5):334-45. PubMed ID: 19322072
    [Abstract] [Full Text] [Related]

  • 36. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
    Ungefroren H, Sebens S, Groth S, Gieseler F, Fändrich F.
    Int J Oncol; 2011 Mar 12; 38(3):797-805. PubMed ID: 21225226
    [Abstract] [Full Text] [Related]

  • 37. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways.
    Tacheau C, Fontaine J, Loy J, Mauviel A, Verrecchia F.
    J Cell Physiol; 2008 Dec 12; 217(3):759-68. PubMed ID: 18668519
    [Abstract] [Full Text] [Related]

  • 38. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
    Liu X.
    Cell Motil Cytoskeleton; 2008 Dec 12; 65(12):935-44. PubMed ID: 18792103
    [Abstract] [Full Text] [Related]

  • 39. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
    Herzer K, Grosse-Wilde A, Krammer PH, Galle PR, Kanzler S.
    Mol Cancer Res; 2008 Jul 12; 6(7):1169-77. PubMed ID: 18644981
    [Abstract] [Full Text] [Related]

  • 40. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma.
    Guo H, Zhang HY, Wang SL, Ye L, Yang GH, Bu H.
    Chin Med J (Engl); 2007 Mar 20; 120(6):515-21. PubMed ID: 17439748
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.